ArticleJournal of molecular modeling2022

Battling BTK mutants with noncovalent inhibitors that overcome Cys481 and Thr474 mutations in Waldenström macroglobulinemia therapy: structural mechanistic insights on the role of fenebrutinib.

Ghazi Elamin et al.PubMed ↗Publisher ↗

No numbers read from the abstract.